BDBM345945 2-(4-Acetyl-2,3,4,5-tetrahydro-benzo[f][1,4]oxazepin-9-ylamino)-N-(2-dimethylamino-ethyl)-N-(2-trifluoromethyl-benzyl)-acetamide::US10202368, Example 20

SMILES CN(C)CCN(Cc1ccccc1C(F)(F)F)C(=O)CNc1cccc2CN(CCOc12)C(C)=O

InChI Key InChIKey=CIYXAYVYNZCSRA-UHFFFAOYSA-N

Data  1 EC50

  Tab Delimited (TSV)   2D SDfile   Computed 3D by Vconf -m prep SDfile
Find this compound or compounds like it in BindingDB:
   Substructure
Similarity at least:  must be >=0.5
Exact match

Activity Spreadsheet -- Enzyme Inhibition Constant Data from BindingDB

Found 1 hit for monomerid = 345945   

TargetAtypical chemokine receptor 3(Human)
Idorsia Pharmaceuticals

US Patent
LigandPNGBDBM345945(US10202368, Example 20 | 2-(4-Acetyl-2,3,4,5-tetra...)
Affinity DataEC50:  73nMAssay Description:The assay is using the PathHunter CHO-K1 CXCR7 β-arrestin cell line from DiscoverX. The system is based on the Enzyme Fragment Complementation T...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/2/2019
Entry Details
Go to US Patent